abstract |
It is an object of the present invention to provide a monoclonal antibody which binds to human XCR1 and comprises an amino acid sequence selected from the group consisting of the 8th, 11th, 12th, 13th, 14th, 16th, 17th, 22nd, , 176th and 177th amino acids of the amino acid sequence of SEQ ID NO: 1 and SEQ ID NO: 2. |